CleanSpace's AGILE respirator has achieved AS/NZS 17420.2:2021 certification, paving the way for commercialisation in Australia and New Zealand alongside its recent European approval.
- Achieved AS/NZS 17420.2:2021 certification
- Dual certification enables global market access
- Targets mining, construction, and industrial sectors
- Designed for comfort including bearded workers
- Nearly two years of R&D underpin product
Certification Opens Australian and New Zealand Market
CleanSpace Holdings Limited (ASX:CSX) has crossed a crucial regulatory threshold with its CleanSpace AGILE powered air purifying respirator (PAPR) now certified to AS/NZS 17420.2:2021. This standard represents Australia and New Zealand’s adoption of the international ISO 17420-2:2021 framework for respiratory protection devices. The certification follows last month’s European EN 12941 (TH2) approval, positioning AGILE for commercialisation across major global markets.
The AS/NZS 17420.2:2021 certification is among the first for PAPRs under this new ISO-based framework in the region, reflecting a rigorous and lengthy approval process. This milestone validates AGILE’s technical credentials against internationally recognised respiratory protection requirements and unlocks a significant revenue opportunity in Australia and New Zealand.
Product Innovation Tailored for Challenging Environments
Developed over nearly two years of focused R&D, CleanSpace AGILE addresses the needs of workers exposed to high particulate environments such as mining, construction, and industrial manufacturing. Its loose-fitting half facepiece design accommodates facial hair, a notable advantage over tight-fitting alternatives, while delivering 99.99% filtration efficiency.
Weighing less than 425 grams and free of belts or hoses, AGILE emphasises comfort and mobility, features aimed at improving worker adoption and productivity. Compatibility with other personal protective equipment further enhances its appeal for organisations aiming to boost respiratory safety compliance.
Strategic Positioning for Growth in Regulated Markets
The dual certification status; AS/NZS 17420.2:2021 for Australia and New Zealand and EN 12941 for Europe; provides CleanSpace with a strong platform to expand its footprint in regulated respiratory protection markets. The company targets sectors where tightening safety regulations and increased focus on worker health are driving demand for advanced respiratory solutions.
CleanSpace’s achievement also underscores its innovation leadership and patent portfolio in respiratory protection technology, reinforcing its competitive edge against traditional industrial brands within an increasingly stringent regulatory landscape.
Next Steps for Commercialisation
With certification hurdles cleared, CleanSpace is now focused on commercialising AGILE across key markets. While the filing does not specify rollout timelines or financial forecasts, the regulatory approvals mark a critical step toward revenue growth in Australia, New Zealand, and Europe.
Bottom Line?
CleanSpace’s AGILE certification marks a pivotal step toward capturing regulated respiratory protection markets, but commercial traction and sales execution will determine its financial impact.
Questions in the middle?
- How quickly will CleanSpace convert certification into sales in Australia and New Zealand?
- What pricing and distribution strategies will CleanSpace deploy to compete with established respiratory brands?
- Will further regulatory approvals in other regions follow to extend AGILE’s global reach?